Craft Alcohol Global D2C Expansion Practical Framework
Japanese sake, to the tables of the world. Breaking free from relying on importers for exports, a D2C strategy that connects directly with overseas enthusiasts.
We provide a practical framework for global D2C expansion utilizing cross-border e-commerce for sake breweries and distilleries. By overcoming the three barriers of complex export regulations, the power of storytelling, and logistics and payment, we aim to directly deliver the makers' stories to overseas enthusiasts and build long-term relationships. We offer a free export market diagnosis, so please feel free to contact us.
basic information
【Specifications】 - A four-layer structure for global D2C in alcoholic beverages (regulations, logistics, payments / storytelling / combination of sales channels / building relationships with enthusiasts) - Global D2C execution roadmap (three steps: selection, direct sales, collaboration) - Comparison framework between traditional exports and the desired future state - Self-diagnosis checklist for preparation for overseas expansion of alcoholic beverages - Export market diagnosis (free of charge) provided
Price range
Delivery Time
Applications/Examples of results
【Uses and Achievements】 - Establishment of a direct sales system for sake, Japanese whiskey, shochu, and awamori overseas - Launch of direct sales to overseas enthusiasts utilizing cross-border e-commerce - Development of multilingual content sharing the stories of breweries, production areas, and drinking methods - Support for compliance with export regulations and obtaining sales permits for Asia, North America, and Europe - Selection of international logistics, temperature control, age verification, and payment partners - Building long-term relationships with overseas enthusiasts through membership systems, limited editions, and brewery tour programs
catalog（1）
Download All Catalogs
Recommended products
Distributors
Accenture transforms change into power, providing 360-degree value to customers, employees, shareholders, partner companies, and society. We support Bristol Myers Squibb by leveraging generative AI and automation to accelerate clinical trials and streamline drug development. We consolidate our full capabilities as a reinvention service to solve the most challenging problems. We guide enterprise transformation to be executed on a larger scale and with greater impact.